Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Science (New York, N.Y.)|December 18, 2010
Cholinergic interneurons control local circuit activity and cocaine conditioningIlana B Witten, Shih-Chun Lin, Matthew Brodsky, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseSusan H Fox, Leonard Verhagen Metman, John G Nutt, et al.Clinical Parkinsonism & Related Disorders|March 25, 2022
Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority studyCynthia Comella, Robert A Hauser, Stuart H Isaacson, et al.Neuron|December 14, 2011
Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcementIlana B Witten, Elizabeth E Steinberg, Soo Yeun Lee, et al.Autonomic Neuroscience : Basic & Clinical|May 17, 2017
Autonomic and electrocardiographic findings in Parkinson's diseaseChristopher H Gibbons, David K Simon, Meilin Huang, et al.Frontiers in Neurology|February 2, 2026
10-year clinical outcomes of subthalamic nucleus versus pallidal deep brain stimulation for Parkinson's disease: VA/NINDS CSP #468FJill L Ostrem, Ping Luo, Frances M Weaver, et al.JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.Pageof 2